Brief: Vincerx Pharma Provides Key Strategic Update

Vincerx Pharma

06/06/2022 22:30

Vincerx Pharma Inc  VINC.O :
    * VINCERX PHARMA PROVIDES KEY STRATEGIC UPDATE
    * VINCERX PHARMA INC - PRIORITIZING PHASE 1B VIP152 STUDIES
TO
FOCUS ON DOUBLE-HIT DLBCL AND CLL
    * VINCERX PHARMA - IND FILINGS FOR VIP236 IN 2H22 AND FOR
VIP943
IN 2H23 REMAIN ON TRACK
    * VINCERX PHARMA INC - STREAMLINING AND REALIGNING RESOURCES
TO
SUPPORT KEY INDICATIONS AND PROGRAMS; EXTENDING ESTIMATED CASH
RUNWAY INTO LATE 2024
    * VINCERX PHARMA - IMPLEMENTING CERTAIN COST REDUCTION
MEASURES,
INCLUDING A 33% REDUCTION OF FULL-TIME EMPLOYEES

Source text for Eikon:  ID:nGNXb1JY6V 
Further company coverage:  VINC.O